Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2010
03/25/2010US20100075924 Dutpase inhibitors
03/25/2010US20100075916 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/25/2010US20100074889 4'-allene-substituted nucleoside derivatives
03/25/2010US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents
03/25/2010US20100071592 Image-forming material
03/25/2010CA2737738A1 Heterocyclic carboxamide compounds
03/25/2010CA2737038A1 Amide compounds, compositions and uses thereof
03/25/2010CA2736971A1 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
03/24/2010EP2164834A2 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
03/24/2010EP2164833A2 Quinazolinamide derivatives
03/24/2010EP2164825A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010EP1902036B1 Process for the preparation of rosuvastatin and intermediates
03/24/2010EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/24/2010CN101679364A heteroarylamide pyrimidone compounds
03/24/2010CN101679314A Compound that is a dual inhibitor of enzymes PDE7 and/or PDE4, pharmaceutical compositions and uses thereof
03/24/2010CN101679313A Axl kinase inhibitors used in cancer or excess proliferative disease
03/24/2010CN101679312A 3,4-dihydroquinazoline derivatives
03/24/2010CN101679311A quinazoline compounds
03/24/2010CN101679310A Alkynylpyrimidines as Tie2 kinase inhibitors
03/24/2010CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
03/24/2010CN101679308A inhibitors of the hedgehog pathway
03/24/2010CN101679307A Co-crystals of cyprodinil and pyrimethanil
03/24/2010CN101679306A Heteroarylamide pyrimidone derivatives
03/24/2010CN101679305A Arylamide pyrimidone derivatives
03/24/2010CN101679294A Non-nucleoside reverse transcriptase inhibitors
03/24/2010CN101679266A PIM kinase inhibitors and methods of their use
03/24/2010CN101679191A Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
03/24/2010CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth
03/24/2010CN101677554A Chemical compounds
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/23/2010US7683225 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency
03/23/2010US7683201 cost efficiency; environmentally friendly
03/23/2010US7683169 integrin inhibiting activity; inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation, tumor metastasis
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683097 Topoisomerase inhibitors
03/23/2010US7683071 for treatment of focal distonia, tremors, and parkinson's disease; administering sodium salt of 5,5-diphenyl barbituric acid
03/23/2010US7683070 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide
03/23/2010US7683058 N-[4-Amino-6-methyl-2-(4-trifluoromethylbenzylamino)-pyrimidin-5-yl]-2-cyclopentylacetamide; potassium ion channels modulators; epilepsy; seizure , anxiety , neuropathic pain and migraine pain disorders
03/23/2010CA2460177C 3-substituted-4-pyrimidone derivatives
03/18/2010WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods
03/18/2010WO2010030722A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
03/18/2010WO2010029756A1 5-[2-(methylthio)ethoxy]pyrimidine-2-amine manufacturing method
03/18/2010WO2010029379A1 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
03/18/2010WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010WO2009024251A8 Use of sulfonanilide compounds as herbicide
03/18/2010US20100069635 Rosuvastatin dehydroabietylamine salt
03/18/2010US20100069634 Pyrimidine non-classical cannabinoid compounds and related methods of use
03/18/2010US20100069418 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069413 Pyrimidine and Quinazoline Derivatives
03/18/2010US20100069408 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/18/2010US20100069405 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
03/18/2010US20100069393 Method of treatment and agents useful for same
03/18/2010US20100069383 Compounds and therapeutical use thereof
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069369 Kinase Inhibitors And Their Uses
03/18/2010US20100069351 Spiro compound and use thereof
03/18/2010US20100069243 Pyrimidylmethyl-Sulfonamide Compounds
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100064450 Agent for dyeing keratin-containing fibers
03/18/2010CA2736530A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2163546A1 Quinazoline derivatives
03/17/2010EP2163541A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2162444A2 An improved process for erlotinib hydrochloride
03/17/2010EP2162443A2 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
03/17/2010CN101671336A Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/17/2010CN101671309A Synthesis method of 6-ethyl-4-hydroxyl-5-fluorine-2-cloro pyridine ammonium salt
03/17/2010CN101671307A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
03/17/2010CN101671301A Heterocyclic substituent acardite derivate and application thereof
03/17/2010CN101671217A Method for preparing organic chlorofluoro compounds from organic polychlorinated compounds
03/16/2010US7678831 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678804 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/16/2010US7678802 Voltage gated sodium and calcium channel inhibitors
03/16/2010US7678790 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents
03/16/2010US7678778 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
03/16/2010US7678156 hair treatment; oxidation color dyes
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/11/2010WO2010028254A2 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/11/2010WO2010028179A1 Heterocyclic compounds as gata modulators
03/11/2010WO2010028174A1 Novel biccyclic compounds as gata modulators
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2010027779A2 Pesticidal compositions
03/11/2010WO2010027448A1 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
03/11/2010WO2010027326A1 Peptide nucleic acid monomers and oligomers
03/11/2010WO2010027097A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors
03/11/2010WO2010027005A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient
03/11/2010WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026095A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010WO2010025871A1 4-halogen alkyl-substituted diaminopyrimidines for use as fungicides
03/11/2010WO2010025863A2 4-alkyl-substituted diaminopyrimidines
03/11/2010WO2010025850A1 Heterocyclically substituted anilinopyrimidines as fungicides
03/11/2010WO2010025833A1 Alkoxy-substituted and alkylthio-substituted anilinopyrimidines
03/11/2010WO2010020432A8 Compounds for treatment of duchenne muscular dystrophy
03/11/2010WO2009156182A3 Uracil derivatives and use thereof
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063283 Process for stereoselective synthesis of lamivudine
03/11/2010US20100063281 Diphenyl amine derivatives having luminescence property
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 427